 | • レポートコード：QYR2104Z5387 • 出版社/出版日：QYResearch / 2021年4月 ※2025年版があります。お問い合わせください。 • レポート形態：英文、PDF、90ページ • 納品方法：Eメール（納期：3日） • 産業分類：医療 |
| Single User | ￥553,800 (USD3,900) | ▷ お問い合わせ |
| Multi User/Five User | ￥830,700 (USD5,850) | ▷ お問い合わせ |
| Enterprise License（同一法人内共有可） | ￥1,107,600 (USD7,800) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| QYResearch社発行の本調査資料では、特殊注射用ジェネリックのグローバル市場（2016年～2027年）について調べ、市場動向、主要企業の市場シェア、種類別市場規模（タイプI、タイプII）、用途別市場規模（腫瘍、心臓血管、中枢神経系、感染症、自己免疫疾患）、主要地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、日本、中国、韓国、インド、東南アジア、中南米、中東、アフリカ等）、関連企業情報などを掲載しています。 ・市場概要 ・特殊注射用ジェネリックの市場動向 ・企業の競争状況、市場シェア ・特殊注射用ジェネリックの種類別市場規模（タイプI、タイプII） ・特殊注射用ジェネリックの用途別市場規模（腫瘍、心臓血管、中枢神経系、感染症、自己免疫疾患） ・特殊注射用ジェネリックの北米市場規模2016-2027（アメリカ、カナダ） ・特殊注射用ジェネリックのヨーロッパ市場規模2016-2027（ドイツ、フランス、イギリス等） ・特殊注射用ジェネリックのアジア市場規模2016-2027（日本、中国、韓国、インド、東南アジア等） ・特殊注射用ジェネリックの中南米市場規模2016-2027（メキシコ、ブラジル） ・特殊注射用ジェネリックの中東・アフリカ市場規模2016-2027（トルコ、サウジアラビア等） ・主要企業情報（Pfizer、Fresenius、Mylan N.V.、Teva Pharmaceutical、Hikma Pharmaceuticals、Novartis AG、Uman Pharma、Baxter、Par Pharmaceutical、Sagent Pharmaceuticals、Teligent） ・結論 |
Market Analysis and Insights: Global Specialty Injectable Generics Market
The global Specialty Injectable Generics market size is projected to reach US$ 16650 million by 2026, from US$ 9378.7 million in 2019, at a CAGR of 8.4% during 2021-2026.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Specialty Injectable Generics market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Specialty Injectable Generics market in terms of revenue.
On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Specialty Injectable Generics market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Specialty Injectable Generics market.
Global Specialty Injectable Generics Scope and Market Size
Specialty Injectable Generics market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Specialty Injectable Generics market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2016-2027.
Segment by Type
Type I
Type II
Segment by Application
Oncology
Cardiovascular
Central Nervous System
Infectious Diseases
Autoimmune Disorders
By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
By Company
Pfizer
Fresenius
Mylan N.V.
Teva Pharmaceutical
Hikma Pharmaceuticals
Novartis AG
Uman Pharma
Baxter
Par Pharmaceutical
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Specialty Injectable Generics Market Size Growth Rate by Type: 2016 VS 2021 VS 2027
1.2.2 Type I
1.2.3 Type II
1.3 Market by Application
1.3.1 Global Specialty Injectable Generics Market Share by Application: 2016 VS 2021 VS 2027
1.3.2 Oncology
1.3.3 Cardiovascular
1.3.4 Central Nervous System
1.3.5 Infectious Diseases
1.3.6 Autoimmune Disorders
1.4 Study Objectives
1.5 Years Considered
2 Global Growth Trends
2.1 Global Specialty Injectable Generics Market Perspective (2016-2027)
2.2 Specialty Injectable Generics Growth Trends by Regions
2.2.1 Specialty Injectable Generics Market Size by Regions: 2016 VS 2021 VS 2027
2.2.2 Specialty Injectable Generics Historic Market Share by Regions (2016-2021)
2.2.3 Specialty Injectable Generics Forecasted Market Size by Regions (2022-2027)
2.3 Specialty Injectable Generics Industry Dynamic
2.3.1 Specialty Injectable Generics Market Trends
2.3.2 Specialty Injectable Generics Market Drivers
2.3.3 Specialty Injectable Generics Market Challenges
2.3.4 Specialty Injectable Generics Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Specialty Injectable Generics Players by Revenue
3.1.1 Global Top Specialty Injectable Generics Players by Revenue (2016-2021)
3.1.2 Global Specialty Injectable Generics Revenue Market Share by Players (2016-2021)
3.2 Global Specialty Injectable Generics Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Players Covered: Ranking by Specialty Injectable Generics Revenue
3.4 Global Specialty Injectable Generics Market Concentration Ratio
3.4.1 Global Specialty Injectable Generics Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Specialty Injectable Generics Revenue in 2020
3.5 Specialty Injectable Generics Key Players Head office and Area Served
3.6 Key Players Specialty Injectable Generics Product Solution and Service
3.7 Date of Enter into Specialty Injectable Generics Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Specialty Injectable Generics Breakdown Data by Type
4.1 Global Specialty Injectable Generics Historic Market Size by Type (2016-2021)
4.2 Global Specialty Injectable Generics Forecasted Market Size by Type (2022-2027)
5 Specialty Injectable Generics Breakdown Data by Application
5.1 Global Specialty Injectable Generics Historic Market Size by Application (2016-2021)
5.2 Global Specialty Injectable Generics Forecasted Market Size by Application (2022-2027)
6 North America
6.1 North America Specialty Injectable Generics Market Size (2016-2027)
6.2 North America Specialty Injectable Generics Market Size by Type
6.2.1 North America Specialty Injectable Generics Market Size by Type (2016-2021)
6.2.2 North America Specialty Injectable Generics Market Size by Type (2022-2027)
6.2.3 North America Specialty Injectable Generics Market Size by Type (2016-2027)
6.3 North America Specialty Injectable Generics Market Size by Application
6.3.1 North America Specialty Injectable Generics Market Size by Application (2016-2021)
6.3.2 North America Specialty Injectable Generics Market Size by Application (2022-2027)
6.3.3 North America Specialty Injectable Generics Market Size by Application (2016-2027)
6.4 North America Specialty Injectable Generics Market Size by Country
6.4.1 North America Specialty Injectable Generics Market Size by Country (2016-2021)
6.4.2 North America Specialty Injectable Generics Market Size by Country (2022-2027)
6.4.3 United States
6.4.3 Canada
7 Europe
7.1 Europe Specialty Injectable Generics Market Size (2016-2027)
7.2 Europe Specialty Injectable Generics Market Size by Type
7.2.1 Europe Specialty Injectable Generics Market Size by Type (2016-2021)
7.2.2 Europe Specialty Injectable Generics Market Size by Type (2022-2027)
7.2.3 Europe Specialty Injectable Generics Market Size by Type (2016-2027)
7.3 Europe Specialty Injectable Generics Market Size by Application
7.3.1 Europe Specialty Injectable Generics Market Size by Application (2016-2021)
7.3.2 Europe Specialty Injectable Generics Market Size by Application (2022-2027)
7.3.3 Europe Specialty Injectable Generics Market Size by Application (2016-2027)
7.4 Europe Specialty Injectable Generics Market Size by Country
7.4.1 Europe Specialty Injectable Generics Market Size by Country (2016-2021)
7.4.2 Europe Specialty Injectable Generics Market Size by Country (2022-2027)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic
8 Asia-Pacific
8.1 Asia-Pacific Specialty Injectable Generics Market Size (2016-2027)
8.2 Asia-Pacific Specialty Injectable Generics Market Size by Type
8.2.1 Asia-Pacific Specialty Injectable Generics Market Size by Type (2016-2021)
8.2.2 Asia-Pacific Specialty Injectable Generics Market Size by Type (2022-2027)
8.2.3 Asia-Pacific Specialty Injectable Generics Market Size by Type (2016-2027)
8.3 Asia-Pacific Specialty Injectable Generics Market Size by Application
8.3.1 Asia-Pacific Specialty Injectable Generics Market Size by Application (2016-2021)
8.3.2 Asia-Pacific Specialty Injectable Generics Market Size by Application (2022-2027)
8.3.3 Asia-Pacific Specialty Injectable Generics Market Size by Application (2016-2027)
8.4 Asia-Pacific Specialty Injectable Generics Market Size by Region
8.4.1 Asia-Pacific Specialty Injectable Generics Market Size by Region (2016-2021)
8.4.2 Asia-Pacific Specialty Injectable Generics Market Size by Region (2022-2027)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia
9 Latin America
9.1 Latin America Specialty Injectable Generics Market Size (2016-2027)
9.2 Latin America Specialty Injectable Generics Market Size by Type
9.2.1 Latin America Specialty Injectable Generics Market Size by Type (2016-2021)
9.2.2 Latin America Specialty Injectable Generics Market Size by Type (2022-2027)
9.2.3 Latin America Specialty Injectable Generics Market Size by Type (2016-2027)
9.3 Latin America Specialty Injectable Generics Market Size by Application
9.3.1 Latin America Specialty Injectable Generics Market Size by Application (2016-2021)
9.3.2 Latin America Specialty Injectable Generics Market Size by Application (2022-2027)
9.3.3 Latin America Specialty Injectable Generics Market Size by Application (2016-2027)
9.4 Latin America Specialty Injectable Generics Market Size by Country
9.4.1 Latin America Specialty Injectable Generics Market Size by Country (2016-2021)
9.4.2 Latin America Specialty Injectable Generics Market Size by Country (2022-2027)
9.4.3 Mexico
9.4.4 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Specialty Injectable Generics Market Size (2016-2027)
10.2 Middle East & Africa Specialty Injectable Generics Market Size by Type
10.2.1 Middle East & Africa Specialty Injectable Generics Market Size by Type (2016-2021)
10.2.2 Middle East & Africa Specialty Injectable Generics Market Size by Type (2022-2027)
10.2.3 Middle East & Africa Specialty Injectable Generics Market Size by Type (2016-2027)
10.3 Middle East & Africa Specialty Injectable Generics Market Size by Application
10.3.1 Middle East & Africa Specialty Injectable Generics Market Size by Application (2016-2021)
10.3.2 Middle East & Africa Specialty Injectable Generics Market Size by Application (2022-2027)
10.3.3 Middle East & Africa Specialty Injectable Generics Market Size by Application (2016-2027)
10.4 Middle East & Africa Specialty Injectable Generics Market Size by Country
10.4.1 Middle East & Africa Specialty Injectable Generics Market Size by Country (2016-2021)
10.4.2 Middle East & Africa Specialty Injectable Generics Market Size by Country (2022-2027)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE
11 Key Players Profiles
11.1 Pfizer
11.1.1 Pfizer Company Details
11.1.2 Pfizer Business Overview
11.1.3 Pfizer Specialty Injectable Generics Introduction
11.1.4 Pfizer Revenue in Specialty Injectable Generics Business (2016-2021)
11.1.5 Pfizer Recent Development
11.2 Fresenius
11.2.1 Fresenius Company Details
11.2.2 Fresenius Business Overview
11.2.3 Fresenius Specialty Injectable Generics Introduction
11.2.4 Fresenius Revenue in Specialty Injectable Generics Business (2016-2021)
11.2.5 Fresenius Recent Development
11.3 Mylan N.V.
11.3.1 Mylan N.V. Company Details
11.3.2 Mylan N.V. Business Overview
11.3.3 Mylan N.V. Specialty Injectable Generics Introduction
11.3.4 Mylan N.V. Revenue in Specialty Injectable Generics Business (2016-2021)
11.3.5 Mylan N.V. Recent Development
11.4 Teva Pharmaceutical
11.4.1 Teva Pharmaceutical Company Details
11.4.2 Teva Pharmaceutical Business Overview
11.4.3 Teva Pharmaceutical Specialty Injectable Generics Introduction
11.4.4 Teva Pharmaceutical Revenue in Specialty Injectable Generics Business (2016-2021)
11.4.5 Teva Pharmaceutical Recent Development
11.5 Hikma Pharmaceuticals
11.5.1 Hikma Pharmaceuticals Company Details
11.5.2 Hikma Pharmaceuticals Business Overview
11.5.3 Hikma Pharmaceuticals Specialty Injectable Generics Introduction
11.5.4 Hikma Pharmaceuticals Revenue in Specialty Injectable Generics Business (2016-2021)
11.5.5 Hikma Pharmaceuticals Recent Development
11.6 Novartis AG
11.6.1 Novartis AG Company Details
11.6.2 Novartis AG Business Overview
11.6.3 Novartis AG Specialty Injectable Generics Introduction
11.6.4 Novartis AG Revenue in Specialty Injectable Generics Business (2016-2021)
11.6.5 Novartis AG Recent Development
11.7 Uman Pharma
11.7.1 Uman Pharma Company Details
11.7.2 Uman Pharma Business Overview
11.7.3 Uman Pharma Specialty Injectable Generics Introduction
11.7.4 Uman Pharma Revenue in Specialty Injectable Generics Business (2016-2021)
11.7.5 Uman Pharma Recent Development
11.8 Baxter
11.8.1 Baxter Company Details
11.8.2 Baxter Business Overview
11.8.3 Baxter Specialty Injectable Generics Introduction
11.8.4 Baxter Revenue in Specialty Injectable Generics Business (2016-2021)
11.8.5 Baxter Recent Development
11.9 Par Pharmaceutical
11.9.1 Par Pharmaceutical Company Details
11.9.2 Par Pharmaceutical Business Overview
11.9.3 Par Pharmaceutical Specialty Injectable Generics Introduction
11.9.4 Par Pharmaceutical Revenue in Specialty Injectable Generics Business (2016-2021)
11.9.5 Par Pharmaceutical Recent Development
11.10 Sagent Pharmaceuticals
11.10.1 Sagent Pharmaceuticals Company Details
11.10.2 Sagent Pharmaceuticals Business Overview
11.10.3 Sagent Pharmaceuticals Specialty Injectable Generics Introduction
11.10.4 Sagent Pharmaceuticals Revenue in Specialty Injectable Generics Business (2016-2021)
11.10.5 Sagent Pharmaceuticals Recent Development
11.11 Teligent
11.11.1 Teligent Company Details
11.11.2 Teligent Business Overview
11.11.3 Teligent Specialty Injectable Generics Introduction
11.11.4 Teligent Revenue in Specialty Injectable Generics Business (2016-2021)
11.11.5 Teligent Recent Development
12 Analyst’s Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
Table 1. Global Specialty Injectable Generics Market Size Growth Rate by Type (US$ Million):2016 VS 2021 VS 2027
Table 2. Key Players of Type I
Table 3. Key Players of Type II
Table 4. Global Specialty Injectable Generics Market Size Growth by Application (US$ Million): 2016 VS 2021 VS 2027
Table 5. Global Specialty Injectable Generics Market Size by Regions (US$ Million): 2016 VS 2021 VS 2027
Table 6. Global Specialty Injectable Generics Market Size by Regions (2016-2021) & (US$ Million)
Table 7. Global Specialty Injectable Generics Market Share by Regions (2016-2021)
Table 8. Global Specialty Injectable Generics Forecasted Market Size by Regions (2022-2027) & (US$ Million)
Table 9. Global Specialty Injectable Generics Market Share by Regions (2022-2027)
Table 10. Specialty Injectable Generics Market Trends
Table 11. Specialty Injectable Generics Market Drivers
Table 12. Specialty Injectable Generics Market Challenges
Table 13. Specialty Injectable Generics Market Restraints
Table 14. Global Specialty Injectable Generics Revenue by Players (2016-2021) & (US$ Million)
Table 15. Global Specialty Injectable Generics Market Share by Players (2016-2021)
Table 16. Global Top Specialty Injectable Generics Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Specialty Injectable Generics as of 2020)
Table 17. Ranking of Global Top Specialty Injectable Generics Companies by Revenue (US$ Million) in 2020
Table 18. Global 5 Largest Players Market Share by Specialty Injectable Generics Revenue (CR5 and HHI) & (2016-2021)
Table 19. Key Players Headquarters and Area Served
Table 20. Key Players Specialty Injectable Generics Product Solution and Service
Table 21. Date of Enter into Specialty Injectable Generics Market
Table 22. Mergers & Acquisitions, Expansion Plans
Table 23. Global Specialty Injectable Generics Market Size by Type (2016-2021) (US$ Million)
Table 24. Global Specialty Injectable Generics Revenue Market Share by Type (2016-2021)
Table 25. Global Specialty Injectable Generics Forecasted Market Size by Type (2022-2027) (US$ Million)
Table 26. Global Specialty Injectable Generics Revenue Market Share by Type (2022-2027) & (US$ Million)
Table 27. Global Specialty Injectable Generics Market Size Share by Application (2016-2021) & (US$ Million)
Table 28. Global Specialty Injectable Generics Revenue Market Share by Application (2016-2021)
Table 29. Global Specialty Injectable Generics Forecasted Market Size by Application (2022-2027) (US$ Million)
Table 30. Global Specialty Injectable Generics Revenue Market Share by Application (2022-2027) & (US$ Million)
Table 31. North America Specialty Injectable Generics Market Size by Type (2016-2021) (US$ Million)
Table 32. North America Specialty Injectable Generics Market Size by Type (2022-2027) & (US$ Million)
Table 33. North America Specialty Injectable Generics Market Size by Application (2016-2021) (US$ Million)
Table 34. North America Specialty Injectable Generics Market Size by Application (2022-2027) & (US$ Million)
Table 35. North America Specialty Injectable Generics Market Size by Country (2016-2021) & (US$ Million)
Table 36. North America Specialty Injectable Generics Market Size by Country (2022-2027) & (US$ Million)
Table 37. Europe Specialty Injectable Generics Market Size by Type (2016-2021) (US$ Million)
Table 38. Europe Specialty Injectable Generics Market Size by Type (2022-2027) & (US$ Million)
Table 39. Europe Specialty Injectable Generics Market Size by Application (2016-2021) (US$ Million)
Table 40. Europe Specialty Injectable Generics Market Size by Application (2022-2027) & (US$ Million)
Table 41. Europe Specialty Injectable Generics Market Size by Country (2016-2021) & (US$ Million)
Table 42. Europe Specialty Injectable Generics Market Size by Country (2022-2027) & (US$ Million)
Table 43. Asia-Pacific Specialty Injectable Generics Market Size by Type (2016-2021) (US$ Million)
Table 44. Asia-Pacific Specialty Injectable Generics Market Size by Type (2022-2027) & (US$ Million)
Table 45. Asia-Pacific Specialty Injectable Generics Market Size by Application (2016-2021) (US$ Million)
Table 46. Asia-Pacific Specialty Injectable Generics Market Size by Application (2022-2027) & (US$ Million)
Table 47. Asia-Pacific Specialty Injectable Generics Market Size by Region (2016-2021) & (US$ Million)
Table 48. Asia-Pacific Specialty Injectable Generics Market Size by Region (2022-2027) & (US$ Million)
Table 49. Latin America Specialty Injectable Generics Market Size by Type (2016-2021) (US$ Million)
Table 50. Latin America Specialty Injectable Generics Market Size by Type (2022-2027) & (US$ Million)
Table 51. Latin America Specialty Injectable Generics Market Size by Application (2016-2021) (US$ Million)
Table 52. Latin America Specialty Injectable Generics Market Size by Application (2022-2027) & (US$ Million)
Table 53. Latin America Specialty Injectable Generics Market Size by Country (2016-2021) & (US$ Million)
Table 54. Latin America Specialty Injectable Generics Market Size by Country (2022-2027) & (US$ Million)
Table 55. Middle East & Africa Specialty Injectable Generics Market Size by Type (2016-2021) (US$ Million)
Table 56. Middle East & Africa Specialty Injectable Generics Market Size by Type (2022-2027) & (US$ Million)
Table 57. Middle East & Africa Specialty Injectable Generics Market Size by Application (2016-2021) (US$ Million)
Table 58. Middle East & Africa Specialty Injectable Generics Market Size by Application (2022-2027) & (US$ Million)
Table 59. Middle East & Africa Specialty Injectable Generics Market Size by Country (2016-2021) & (US$ Million)
Table 60. Middle East & Africa Specialty Injectable Generics Market Size by Country (2022-2027) & (US$ Million)
Table 61. Pfizer Company Details
Table 62. Pfizer Business Overview
Table 63. Pfizer Specialty Injectable Generics Product
Table 64. Pfizer Revenue in Specialty Injectable Generics Business (2016-2021) & (US$ Million)
Table 65. Pfizer Recent Development
Table 66. Fresenius Company Details
Table 67. Fresenius Business Overview
Table 68. Fresenius Specialty Injectable Generics Product
Table 69. Fresenius Revenue in Specialty Injectable Generics Business (2016-2021) & (US$ Million)
Table 70. Fresenius Recent Development
Table 71. Mylan N.V. Company Details
Table 72. Mylan N.V. Business Overview
Table 73. Mylan N.V. Specialty Injectable Generics Product
Table 74. Mylan N.V. Revenue in Specialty Injectable Generics Business (2016-2021) & (US$ Million)
Table 75. Mylan N.V. Recent Development
Table 76. Teva Pharmaceutical Company Details
Table 77. Teva Pharmaceutical Business Overview
Table 78. Teva Pharmaceutical Specialty Injectable Generics Product
Table 79. Teva Pharmaceutical Revenue in Specialty Injectable Generics Business (2016-2021) & (US$ Million)
Table 80. Teva Pharmaceutical Recent Development
Table 81. Hikma Pharmaceuticals Company Details
Table 82. Hikma Pharmaceuticals Business Overview
Table 83. Hikma Pharmaceuticals Specialty Injectable Generics Product
Table 84. Hikma Pharmaceuticals Revenue in Specialty Injectable Generics Business (2016-2021) & (US$ Million)
Table 85. Hikma Pharmaceuticals Recent Development
Table 86. Novartis AG Company Details
Table 87. Novartis AG Business Overview
Table 88. Novartis AG Specialty Injectable Generics Product
Table 89. Novartis AG Revenue in Specialty Injectable Generics Business (2016-2021) & (US$ Million)
Table 90. Novartis AG Recent Development
Table 91. Uman Pharma Company Details
Table 92. Uman Pharma Business Overview
Table 93. Uman Pharma Specialty Injectable Generics Product
Table 94. Uman Pharma Revenue in Specialty Injectable Generics Business (2016-2021) & (US$ Million)
Table 95. Uman Pharma Recent Development
Table 96. Baxter Company Details
Table 97. Baxter Business Overview
Table 98. Baxter Revenue in Specialty Injectable Generics Business (2016-2021) & (US$ Million)
Table 99. Baxter Recent Development
Table 100. Par Pharmaceutical Company Details
Table 101. Par Pharmaceutical Business Overview
Table 102. Par Pharmaceutical Specialty Injectable Generics Product
Table 103. Par Pharmaceutical Revenue in Specialty Injectable Generics Business (2016-2021) & (US$ Million)
Table 104. Par Pharmaceutical Recent Development
Table 105. Sagent Pharmaceuticals Company Details
Table 106. Sagent Pharmaceuticals Business Overview
Table 107. Sagent Pharmaceuticals Specialty Injectable Generics Product
Table 108. Sagent Pharmaceuticals Revenue in Specialty Injectable Generics Business (2016-2021) & (US$ Million)
Table 109. Sagent Pharmaceuticals Recent Development
Table 110. Teligent Company Details
Table 111. Teligent Business Overview
Table 112. Teligent Specialty Injectable Generics Product
Table 113. Teligent Revenue in Specialty Injectable Generics Business (2016-2021) & (US$ Million)
Table 114. Teligent Recent Development
Table 115. Research Programs/Design for This Report
Table 116. Key Data Information from Secondary Sources
Table 117. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Specialty Injectable Generics Market Share by Type: 2020 VS 2027
Figure 2. Type I Features
Figure 3. Type II Features
Figure 4. Global Specialty Injectable Generics Market Share by Application: 2020 VS 2027
Figure 5. Oncology Case Studies
Figure 6. Cardiovascular Case Studies
Figure 7. Central Nervous System Case Studies
Figure 8. Infectious Diseases Case Studies
Figure 9. Autoimmune Disorders Case Studies
Figure 10. Specialty Injectable Generics Report Years Considered
Figure 11. Global Specialty Injectable Generics Market Size (US$ Million), Year-over-Year: 2016-2027
Figure 12. Global Specialty Injectable Generics Market Size (US$ Million), 2016 VS 2021 VS 2027
Figure 13. Global Specialty Injectable Generics Market Share by Regions: 2020 VS 2027
Figure 14. Global Specialty Injectable Generics Market Share by Regions (2022-2027)
Figure 15. Global Specialty Injectable Generics Market Share by Players in 2020
Figure 16. Global Top Specialty Injectable Generics Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Specialty Injectable Generics as of 2020
Figure 17. The Top 10 and 5 Players Market Share by Specialty Injectable Generics Revenue in 2020
Figure 18. Global Specialty Injectable Generics Revenue Market Share by Type (2016-2021)
Figure 19. Global Specialty Injectable Generics Revenue Market Share by Type (2022-2027)
Figure 20. North America Specialty Injectable Generics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 21. North America Specialty Injectable Generics Market Share by Type (2016-2027)
Figure 22. North America Specialty Injectable Generics Market Share by Application (2016-2027)
Figure 23. North America Specialty Injectable Generics Market Share by Country (2016-2027)
Figure 24. United States Specialty Injectable Generics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 25. Canada Specialty Injectable Generics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 26. Europe Specialty Injectable Generics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 27. Europe Specialty Injectable Generics Market Share by Type (2016-2027)
Figure 28. Europe Specialty Injectable Generics Market Share by Application (2016-2027)
Figure 29. Europe Specialty Injectable Generics Market Share by Country (2016-2027)
Figure 30. Germany Specialty Injectable Generics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 31. France Specialty Injectable Generics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 32. U.K. Specialty Injectable Generics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 33. Italy Specialty Injectable Generics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 34. Russia Specialty Injectable Generics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 35. Nordic Specialty Injectable Generics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 36. Asia-Pacific Specialty Injectable Generics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 37. Asia-Pacific Specialty Injectable Generics Market Share by Type (2016-2027)
Figure 38. Asia-Pacific Specialty Injectable Generics Market Share by Application (2016-2027)
Figure 39. Asia-Pacific Specialty Injectable Generics Market Share by Region (2016-2027)
Figure 40. China Specialty Injectable Generics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 41. Japan Specialty Injectable Generics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 42. South Korea Specialty Injectable Generics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 43. Southeast Asia Specialty Injectable Generics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 44. India Specialty Injectable Generics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 45. Australia Specialty Injectable Generics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 46. Latin America Specialty Injectable Generics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 47. Latin America Specialty Injectable Generics Market Share by Type (2016-2027)
Figure 48. Latin America Specialty Injectable Generics Market Share by Application (2016-2027)
Figure 49. Latin America Specialty Injectable Generics Market Share by Country (2016-2027)
Figure 50. Mexico Specialty Injectable Generics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 51. Brazil Specialty Injectable Generics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 52. Middle East & Africa Specialty Injectable Generics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 53. Middle East & Africa Specialty Injectable Generics Market Share by Type (2016-2027)
Figure 54. Middle East & Africa Specialty Injectable Generics Market Share by Application (2016-2027)
Figure 55. Middle East & Africa Specialty Injectable Generics Market Share by Country (2016-2027)
Figure 56. Turkey Specialty Injectable Generics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 57. Saudi Arabia Specialty Injectable Generics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 58. UAE Specialty Injectable Generics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 59. Pfizer Revenue Growth Rate in Specialty Injectable Generics Business (2016-2021)
Figure 60. Fresenius Revenue Growth Rate in Specialty Injectable Generics Business (2016-2021)
Figure 61. Mylan N.V. Revenue Growth Rate in Specialty Injectable Generics Business (2016-2021)
Figure 62. Teva Pharmaceutical Revenue Growth Rate in Specialty Injectable Generics Business (2016-2021)
Figure 63. Hikma Pharmaceuticals Revenue Growth Rate in Specialty Injectable Generics Business (2016-2021)
Figure 64. Novartis AG Revenue Growth Rate in Specialty Injectable Generics Business (2016-2021)
Figure 65. Uman Pharma Revenue Growth Rate in Specialty Injectable Generics Business (2016-2021)
Figure 66. Baxter Revenue Growth Rate in Specialty Injectable Generics Business (2016-2021)
Figure 67. Par Pharmaceutical Revenue Growth Rate in Specialty Injectable Generics Business (2016-2021)
Figure 68. Sagent Pharmaceuticals Revenue Growth Rate in Specialty Injectable Generics Business (2016-2021)
Figure 69. Teligent Revenue Growth Rate in Specialty Injectable Generics Business (2016-2021)
Figure 70. Bottom-up and Top-down Approaches for This Report
Figure 71. Data Triangulation
Figure 72. Key Executives Interviewed
世界の中枢神経系（CNS）障害治療市場規模・現状・予測（2021年-2027年） Central Nervous System (CNS) disorders are also called as neurological and psychiatric disorders. CNS disorders can affect either the brain or spinal cord, or both. Depression is the dominated market of CNS Disorders Therapeutics Market Analysis and Insights: Global Central Nervous System Disorders …- 世界の注入型ドラッグデリバリー市場規模・現状・予測（2021年-2027年） Injectable drug delivery is defined as introduction of a drug or drugs in the patient by using a delivery device. Injectables allow the transport of drugs formulated in liquid form, directly in the body. Even though, they may be designed to transport the drug to specific part of the body. North Amer…
- 世界の中枢神経系（CNS）治療市場規模・現状・予測（2021年-2027年） The central nervous system (CNS) is the part of thenervous system consisting of the brain and spinal cord. In this report, we study the drugs for central nervous system disease. Market Analysis and Insights: Global Central Nervous System Treatment Market The global Central Nervous System Treatment m…
- 世界の中枢神経系（CNS）治療市場規模・現状・予測（2021年-2027年） The central nervous system (CNS) is the part of thenervous system consisting of the brain and spinal cord. In this report, we study the drugs for central nervous system disease. Market Analysis and Insights: Global Central Nervous System Therapeutic Market The global Central Nervous System Therapeut…
- 世界の中枢神経系（CNS）治療市場規模・現状・予測（2021年-2027年） A central nervous system (CNS) disease can affect either the brain or the spinal cord which leads to neurological or psychiatric disorders. Advancements in diagnostics, therapeutics and drug discovery techniques will further trigger the growth of central nervous system therapeutic market. Market Ana…